Intranasal Application of Xenon Reduces Opioid Requirement and Postoperative Pain in Patients Undergoing Major Abdominal Surgery
Authors:
Open Access
- 1 August 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 115 (2) , 398-407
Abstract
Xenon acts in part as an N -methyl-d-aspartate receptor antagonist Whether low concentrations of xenon affect intraoperative analgesia is unknownKeywords
This publication has 58 references indexed in Scilit:
- Noble Gas Xenon Is a Novel Adenosine Triphosphate-sensitive Potassium Channel OpenerAnesthesiology, 2010
- Non-invasive Systemic Drug Delivery: Developability Considerations for Alternate Routes of AdministrationJournal of Pharmaceutical Sciences, 2010
- Xenon-induced changes in CNS sensitization to painNeuroImage, 2010
- Neuronal Preconditioning by Inhalational AnestheticsAnesthesiology, 2009
- Management of acute postoperative pain: Still a long way to go!Pain, 2008
- Xenon Blocks the Induction of Synaptic Long-Term Potentiation in Pain Pathways in the Rat Spinal Cord In VivoAnesthesia & Analgesia, 2007
- Understanding LTP in Pain PathwaysMolecular Pain, 2007
- Preemptive Analgesia at the CrossroadAnesthesia & Analgesia, 2005
- Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawalPain, 2003
- Safety and efficacy of xenon in routine use as an inhalational anaestheticThe Lancet, 1990